Epizyme EPZM

Quarterly report 2022-Q2
added 08-09-2022

Epizyme DIO Ratio 2011-2026 | EPZM

Annual DIO Ratio Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	754	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
754	754	754

Quarterly DIO Ratio Epizyme

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	59.2	19.7	167	262	297	467	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
467	19.7	212

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Happiness Biotech Group Limited HAPP	1.91 K	-	1.35 %	$ 17.8 M	China
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.62	-0.61 %	$ 431 M	Britain
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Anika Therapeutics ANIK	159	$ 15.14	2.16 %	$ 217 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Coherus BioSciences CHRS	97.5	$ 1.51	2.03 %	$ 177 M	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 20.47	4.97 %	$ 2.6 B	USA